CoChat

Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53

Open access
Song, Young, Lee, Woo, Lee, Yong-ho, Kang, Eun, Cha, Bong-Soo, Lee, Byung-Wan · 2016 · International Journal of Molecular Sciences

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Metformin is known to alleviate hepatosteatosis by inducing 5’ adenosine monophosphate (AMP)-kinase-independent, sirtuin 1 (SIRT1)-mediated autophagy. Dysfunctional mitophagy in response to glucolipotoxicities might play an important role in hepatosteatosis. Here, we investigated the mechanism by which metformin induces mitophagy through restoration of the suppressed Parkin-mediated mitophagy. To this end, our ob/ob mice were divided into three groups: (1) ad libitum feeding of a standard chow diet; (2) intraperitoneal injections of metformin 300 mg/kg; and (3) 3 g/day caloric restriction (CR). HepG2 cells were treated with palmitate (PA) plus high glucose in the absence or presence of metformin. We detected enhanced mitophagy in ob/ob mice treated with metformin or CR, whereas mitochondrial spheroids were observed in mice fed ad libitum. Metabolically stressed ob/ob mice and PA-treated HepG2 cells showed an increase in expression of endoplasmic reticulum (ER) stress markers and cytosolic p53. Cytosolic p53 inhibited mitophagy by disturbing the mitochondrial translocation of Parkin, as demonstrated by immunoprecipitation. However, metformin decreased ER stress and p53 expression, resulting in induction of Parkin-mediated mitophagy. Furthermore, pifithrin-α, a specific inhibitor of p53, increased mitochondrial incorporation into autophagosomes. Taken together, these results indicate that metformin treatment facilitates Parkin-mediated mitophagy rather than mitochondrial spheroid formation by decreasing the inhibitory interaction with cytosolic p53 and increasing degradation of mitofusins.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms17010122

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Metformin induced mitophagy. Electron microscopy was performed on hepatocytes from ob/ob mice under ad libitum feeding of chow diet (A-a), caloric restriction (A-b), and ad libitum feeding of chow diet with 300 mg/kg metformin treatment (A-c). In the ad libitum group, spheroid mitochondria were readily detected. However, in the metformin-treated group, autophagic double membranes were detected, indicating mitophagy; (B) co-localization between a marker of autophagosomes (LC3) and a mitochondrial marker (MitoTracker Red) was assessed in HepG2 cells stably transfected with green fluorescent protein (GFP)-LC3. Although there was little co-localization between mitochondria and autophagosomes in the 0.25 mM palmitate-treated HepG2 cells, LC3-labeled structures were seen surrounding the fragmented mitochondria in cells treated with 0.5 mM metformin and 0.25 mM palmitate. Scale bar = 20 μm.
Figure 1 Metformin induced mitophagy. Electron microscopy was performed on hepatocytes from ob/ob mice under ad libitum feeding of chow diet (A-a), caloric restriction (A-b), and ad libitum feeding of chow diet with 300 mg/kg metformin treatment (A-c). In the ad libitum group, spheroid mitochondria were readily detected. However, in the metformin-treated group, autophagic double membranes were detected, indicating mitophagy; (B) co-localization between a marker of autophagosomes (LC3) and a mitochondrial marker (MitoTracker Red) was assessed in HepG2 cells stably transfected with green fluorescent protein (GFP)-LC3. Although there was little co-localization between mitochondria and autophagosomes in the 0.25 mM palmitate-treated HepG2 cells, LC3-labeled structures were seen surrounding the fragmented mitochondria in cells treated with 0.5 mM metformin and 0.25 mM palmitate. Scale bar = 20 μm.CC BY · PubMed Central
Figure 2 Metformin restored the Parkin-mediated mitophagy inhibited by glucolipotoxicity-induced cytosolic p53. Western blotting analysis was performed to assess cytosolic p53 levels with the cytosolic fractions isolated from palmitate- (A-a) or metformin- (A-b) and 35 mM glucose-treated HepG2 cells; the expression of cytosolic p53 protein was assessed following 0.5 mM metformin and/or 0.25 mM palmitate with 35 mM glucose treatment of HepG2 cells (B-a) or in hepatocytes from ob/ob mice with ad libitum feeding of chow diet, caloric restriction, and ad libitum feeding of chow diet with 300 mg/kg metformin treatment (B-b); (C) Expression of Parkin (green) on mitochondria (MitoTracker Red) was observed with a confocal microscopy. The bottom panels show enlarged views of the boxed areas. The yellow dots indicate the mitochondria that co-localize with Parkin. The cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria depending on the conditions used in the HepG2 cells; a co-immunoprecipitation assay was conducted to investigate the interaction between p53 and Parkin, depending on the conditions used in the HepG2 cells (D-a) or in hepatocytes from mice (D-b). GAPDH or COX IV was used for normalization. Values displayed are mean ± SEM (n = 3 independent experiments, respectively). Scale bar: white = 20 μm, yellow = 10 μm. Asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant differences. Abbreviation: Mfn1, mitofusin1.
Figure 2 Metformin restored the Parkin-mediated mitophagy inhibited by glucolipotoxicity-induced cytosolic p53. Western blotting analysis was performed to assess cytosolic p53 levels with the cytosolic fractions isolated from palmitate- (A-a) or metformin- (A-b) and 35 mM glucose-treated HepG2 cells; the expression of cytosolic p53 protein was assessed following 0.5 mM metformin and/or 0.25 mM palmitate with 35 mM glucose treatment of HepG2 cells (B-a) or in hepatocytes from ob/ob mice with ad libitum feeding of chow diet, caloric restriction, and ad libitum feeding of chow diet with 300 mg/kg metformin treatment (B-b); (C) Expression of Parkin (green) on mitochondria (MitoTracker Red) was observed with a confocal microscopy. The bottom panels show enlarged views of the boxed areas. The yellow dots indicate the mitochondria that co-localize with Parkin. The cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria depending on the conditions used in the HepG2 cells; a co-immunoprecipitation assay was conducted to investigate the interaction between p53 and Parkin, depending on the conditions used in the HepG2 cells (D-a) or in hepatocytes from mice (D-b). GAPDH or COX IV was used for normalization. Values displayed are mean ± SEM (n = 3 independent experiments, respectively). Scale bar: white = 20 μm, yellow = 10 μm. Asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant differences. Abbreviation: Mfn1, mitofusin1.CC BY · PubMed Central
Figure 3 Metformin restored Parkin-mediated mitophagy inhibited by glucolipotoxicity-induced ER stress. The expression of ER stress markers was assessed following 0.5 mM metformin and/or 0.25 mM palmitate with 35 mM glucose treatment of HepG2 cells (A-a) or in hepatocytes from ob/ob mice with ad libitum feeding of chow diet, caloric restriction, or ad libitum feeding of chow diet with 300 mg/kg metformin treatment (A-b) using Western blotting analysis. Values displayed are mean ± SEM (n = 3 independent experiments, respectively); (B) the expression of ER stress markers and p53 protein was assessed in response to thapsigargin in HepG2 cells; (C-a) cell viability was assessed in HepG2 cells exposed to 0.1 μM thapsigargin and/or 0.5 mM metformin using CCK-8. Values displayed are mean ± SEM (n = 5 independent experiments); (C-b) the expression of an ER stress marker was also examined under these conditions; (C-c) the cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria, depending on the conditions used. Values displayed are mean ± SEM (n = 3 independent experiments, respectively). GAPDH or COX IV was used for normalization. Asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant differences. Abbreviation: Mfn1, mitofusin1; CCK-8, cell counting kit-8.
Figure 3 Metformin restored Parkin-mediated mitophagy inhibited by glucolipotoxicity-induced ER stress. The expression of ER stress markers was assessed following 0.5 mM metformin and/or 0.25 mM palmitate with 35 mM glucose treatment of HepG2 cells (A-a) or in hepatocytes from ob/ob mice with ad libitum feeding of chow diet, caloric restriction, or ad libitum feeding of chow diet with 300 mg/kg metformin treatment (A-b) using Western blotting analysis. Values displayed are mean ± SEM (n = 3 independent experiments, respectively); (B) the expression of ER stress markers and p53 protein was assessed in response to thapsigargin in HepG2 cells; (C-a) cell viability was assessed in HepG2 cells exposed to 0.1 μM thapsigargin and/or 0.5 mM metformin using CCK-8. Values displayed are mean ± SEM (n = 5 independent experiments); (C-b) the expression of an ER stress marker was also examined under these conditions; (C-c) the cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria, depending on the conditions used. Values displayed are mean ± SEM (n = 3 independent experiments, respectively). GAPDH or COX IV was used for normalization. Asterisks (* p < 0.05, ** p < 0.01, *** p < 0.001) indicate significant differences. Abbreviation: Mfn1, mitofusin1; CCK-8, cell counting kit-8.CC BY · PubMed Central
Figure 4 A p53 inhibitor restored the Parkin-mediated mitophagy inhibited by glucolipotoxicity. (A-a) the expression of cytosolic p53 was assessed in HepG2 cells treated with 50 μM PFT-α, a p53 inhibitor, and/or 0.25 mM palmitate with 35 mM glucose using Western blotting analysis; (A-b) the cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria, depending on the conditions used. Exposure time of Western blotting was long, compared to Figure 2C; (B) co-localization was assessed between a marker of autophagosomes (LC3) and a mitochondrial marker (MitoTracker Red) in HepG2 cells stably transfected with GFP-LC3, depending on the conditions used. LC3-labeled structures were observed surrounding the fragmented mitochondria in cells treated with PFT-α and palmitate, although there was little co-localization between mitochondria and autophagosomes in cells treated with 0.25 mM palmitate alone. Scale bar = 20 μm. Abbreviation: Mfn1, mitofusin1; PFT-α, pifithrin-α.
Figure 4 A p53 inhibitor restored the Parkin-mediated mitophagy inhibited by glucolipotoxicity. (A-a) the expression of cytosolic p53 was assessed in HepG2 cells treated with 50 μM PFT-α, a p53 inhibitor, and/or 0.25 mM palmitate with 35 mM glucose using Western blotting analysis; (A-b) the cytosolic and mitochondrial fractionation experiments demonstrated Parkin translocation from the cytosol to mitochondria, depending on the conditions used. Exposure time of Western blotting was long, compared to Figure 2C; (B) co-localization was assessed between a marker of autophagosomes (LC3) and a mitochondrial marker (MitoTracker Red) in HepG2 cells stably transfected with GFP-LC3, depending on the conditions used. LC3-labeled structures were observed surrounding the fragmented mitochondria in cells treated with PFT-α and palmitate, although there was little co-localization between mitochondria and autophagosomes in cells treated with 0.25 mM palmitate alone. Scale bar = 20 μm. Abbreviation: Mfn1, mitofusin1; PFT-α, pifithrin-α.CC BY · PubMed Central
Figure 5 Summary of the working thesis of this study. See the text for details. Black and red arrows indicate the effects of glucolipotoxicity and the drugs (metformin or PFTα), respectively.
Figure 5 Summary of the working thesis of this study. See the text for details. Black and red arrows indicate the effects of glucolipotoxicity and the drugs (metformin or PFTα), respectively.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 98

Metadata

Authors
Song, Y., Lee, W., Lee, Y.-H., Kang, E., Cha, B.-S., & Lee, B.-W.
Affiliations
  • Yonsei University (KR)
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, 03722 Seoul, Korea
Corresponding author
Lee, Byung-Wan
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2016-01-16
Volume
17
Issue
1
Pages
122
ISSN
1422-0067 (ISSN-L)
OpenAlex
W2278836749
Cited by
98
References
27
Citations by year
2026: 5 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 19 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 4
FWCI
5.00
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Research Foundation of Korea (2014R1A1A2057906)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
metformin, Parkin, mitophagy, hepatic steatosis, endoplasmic reticulum stress, palmitate, high glucose, caloric restriction, ob/ob mice, pifithrin-alpha, SIRT1
MeSH terms
Animals, Cell Survival, Diet, Fatty Liver, Gene Expression Regulation, Glucose, Humans, Hypoglycemic Agents, Metformin, Mice, Obese, Mitochondria, Toluene, Signal Transduction, Tumor Suppressor Protein p53, Palmitic Acid, Caloric Restriction, Ubiquitin-Protein Ligases, Mice, Benzothiazoles, Sirtuin 1, Hep G2 Cells, Endoplasmic Reticulum Stress, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.